Skip to main content

Revance Therapeutics, Inc. - Common Stock (NQ: RVNC )

3.080 +0.010 (+0.33%)
Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2024 Add to My Watchlist

Other Filings

Form SC 13G/A
Source: SEC/Edgar
February 02, 2017
Form 8-K
Source: SEC/Edgar
January 31, 2017
Form SC 13G/A
Source: SEC/Edgar
January 24, 2017
Form 8-K
Source: SEC/Edgar
January 11, 2017
Form SC 13G/A
Source: SEC/Edgar
January 10, 2017
Form 8-K
Source: SEC/Edgar
January 04, 2017
Form 8-K
Source: SEC/Edgar
December 11, 2016
Form 8-K
Source: SEC/Edgar
November 02, 2016
Form 8-K
Source: SEC/Edgar
August 03, 2016
Form CT ORDER
Source: SEC/Edgar
July 21, 2016
Form 8-K
Source: SEC/Edgar
July 04, 2016
Form 8-K
Source: SEC/Edgar
June 12, 2016
Form 8-K
Source: SEC/Edgar
June 02, 2016
Form 8-K
Source: SEC/Edgar
May 08, 2016
Form 424B5
Source: SEC/Edgar
March 24, 2016
Form EFFECT
Source: SEC/Edgar
March 24, 2016
Form DEF 14A
Source: SEC/Edgar
March 17, 2016
Form 8-K
Source: SEC/Edgar
March 06, 2016
Form S-3
Source: SEC/Edgar
March 06, 2016
Form S-8
Source: SEC/Edgar
March 03, 2016
Form 8-K
Source: SEC/Edgar
March 01, 2016
Form 8-K
Source: SEC/Edgar
February 11, 2016
Form SC 13G
Source: SEC/Edgar
February 11, 2016
Form SC 13G/A
Source: SEC/Edgar
February 09, 2016
Form SC 13G/A
Source: SEC/Edgar
February 08, 2016
Form SC 13G
Source: SEC/Edgar
January 27, 2016
Form SC 13G
Source: SEC/Edgar
January 25, 2016
Form SC 13G/A
Source: SEC/Edgar
January 20, 2016
Form CT ORDER
Source: SEC/Edgar
January 11, 2016
Form 8-K
Source: SEC/Edgar
January 06, 2016
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.